Evaluation of opioid prescribing after rescheduling of hydrocodone-containing products-Reference-Cited by-同舟云学术

Evaluation of opioid prescribing after rescheduling of hydrocodone-containing products

Published:2017-12-15 Issue:24 Volume:74 Page:2046-2053
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Bernhardt M. Brooke¹,Taylor Ruston S.¹,Hagan Joseph L.²,Patel Nihar³,Chumpitazi Corrie E.⁴,Fox Karin A.⁵,Glover Chris³

Affiliation:

1. Department of Pharmacy, Texas Children’s Hospital, Houston, TX

2. Department of Neonatology, Texas Children’s Hospital, Houston, TX

3. Department of Pediatric Anesthesiology, Baylor College of Medicine, Houston, TX

4. Department of Pediatrics, Section of Emergency Medicine, Baylor College of Medicine, Houston, TX

5. Department of Obstetrics and Gynecology, Baylor College of Medicine/Texas Children’s Hospital Pavilion for Women, Houston, TX

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/74/24/2046/28336862/ajhp2046.pdf

Reference26 articles.

1. Centers for Disease Control and Prevention. WONDER online databases. https://wonder.cdc.gov/ (accessed 2017 Sep 28).

2. Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: summary of national findings. www.samhsa.gov/data/sites/default/files/NSDUHresults2012.pdf (accessed 2017 Aug 24).

3. FDA advisers support rescheduling of hydrocodone products;Traynor;Am J Health-Syst Pharm,2013

4. Drug Enforcement Administration. 21 U.S.C. Controlled Substances Act. www.deadiversion.usdoj.gov/21cfr/21usc/ (accessed 2017 Aug 24).

5. DEA reschedules hydrocodone, makes changes to controlled substance disposal;Traynor;Am J Health-Syst Pharm,2014

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Competitive effects of federal and state opioid restrictions: Evidence from the controlled substance laws;Journal of Health Economics;2023-09

2. Impact of Hydrocodone Rescheduling on Dental Prescribing of Opioids;JDR Clinical & Translational Research;2022-06-16

3. State-level response to gabapentin misuse in the United States: Implications and future direction;American Journal of Health-System Pharmacy;2021-12-24

4. Opioid epidemic and prescribing in hospice and palliative care: a review of the literature;International Journal of Palliative Nursing;2021-07-02

5. Opioid Exposures Reported to U.S. Poison Centers;Substance Use & Misuse;2021-05-03